To develop and validate a machine learning model based on chest CT and clinical risk factors to predict secondary aspergillus infection in hospitalized COVID-19 patients.

This retrospective study included 291 COVID-19 patients with complete clinical data between December 2022 and March 2024, and some (n=82) of them developed secondary aspergillus infection after admission. Patients were divided into training (n=162), internal validation (n=69) and external validation (n=60) cohorts. The least absolute shrinkage and selection operator regression was applied to select the most significant image features extracted from chest CT. Univariate and multivariate logistic regression analyses were performed to develop a multifactorial model, which integrated chest CT with clinical risk factors, to predict secondary aspergillus infection in hospitalized COVID-19 patients. The performance of the constructed models was assessed with the receiver operating characteristic curve and the area under the curve (AUC). The clinical application value of the models was comprehensively evaluated using decision curve analysis (DCA).

Eleven radiomics features and seven clinical risk factors were selected to develop prediction models. The multifactorial model demonstrated a favorable predictive performance with the highest AUC values of 0.98 (95% CI, 0.96-1.00) in the training cohort, 0.98 (95% CI, 0.96-1.00) in the internal validation cohort, and 0.87 (95% CI, 0.75-0.99) in the external validation cohort, which was significantly superior to the models relied solely on chest CT or clinical risk factors. The calibration curves from Hosmer-Lemeshow tests showed that there were no significant differences in the training cohort (p=0.359) and internal validation cohort (p=0.941), suggesting the good performance of the multifactorial model. DCA indicated that the multifactorial model exhibited better performance than others.

The multifactorial model can serve as a reliable tool for predicting the risk of COVID-19-associated pulmonary aspergillosis.

The proposed AI-based diagnostic system aims to predict the respiratory support required for COVID-19 patients by analyzing the correlation between COVID-19 lesions and the level of respiratory support provided to the patients. Computed tomography (CT) imaging will be used to analyze the three levels of respiratory support received by the patient: Level 0 (minimum support), Level 1 (non-invasive support such as soft oxygen), and Level 2 (invasive support such as mechanical ventilation). The system will begin by segmenting the COVID-19 lesions from the CT images and creating an appearance model for each lesion using a 2D, rotation-invariant, Markov-Gibbs random field (MGRF) model. Three MGRF-based models will be created, one for each level of respiratory support. This suggests that the system will be able to differentiate between different levels of severity in COVID-19 patients. The system will decide for each patient using a neural network-based fusion system, which combines the estimates of the Gibbs energy from the three MGRF-based models. The proposed system were assessed using 307 COVID-19-infected patients, achieving an accuracy of [Formula: see text], a sensitivity of [Formula: see text], and a specificity of [Formula: see text], indicating a high level of prediction accuracy.

Nowadays, COVID severity prediction has attracted widely in medical research because of the disease severity. Hence, the image processing application is also utilized to analyze COVID severity identification using lungs X-ray images. Thus, several intelligent schemes were employed to detect the COVID-affected part of the lungs X-ray images. However, the traditional neural approaches reported less severity classification accuracy due to the image complexity score. So, the present study has presented a novel chimp-based Adaboost Severity Analysis (CbASA) implemented in the MATLAB environment. Hence, the lung's X-ray images are utilized to test the working performance of the designed model. All public imaging data sources contain more noisy features, so the noise features are removed in the initial hidden layer of the novel CbASA then the noise-free data is imported into the classification phase. Feature extraction, segmentation, and severity specification have been performed in the classification layer. Finally, the performance of the classification score has been measured and compared with other models. Subsequently, the presented novel CbASA has earned the finest classification outcome.

The objective of the present study is to classify chest X-ray (CXR) images into COVID-positive and normal categories with the optimal number of features extracted from the images. The successful optimal feature selection algorithm that can represent images and the classification algorithm with good classification ability has been determined as the result of experiments.

This study presented a framework for the automatic detection of COVID-19 from the CXR images. To enhance small details, textures, and contrast of the images, contrast limited adaptive histogram equalization was used. Features were extracted from the first-order statistics, Gray-Level Co-occurrence Matrix, Gray-Level Run Length Matrix, local binary pattern, Law's Texture Energy Measures, Discrete Wavelet Transform, and Zernikes' Moments using an image feature extraction tool "pyFeats. For the feature selection, three nature-inspired optimization algorithms, Grey Wolf Optimization, Particle Swarm Optimization (PSO), and Genetic Algorithm, were used. For classification, Random Forest classifier, K-Nearest Neighbour classifier, support vector machine (SVM) classifier, and light gradient boosting model classifier were used.

For all the feature selection methods, the SVM classifier gives the most accurate and precise result compared to other classification models. Furthermore, in feature selection methods, PSO gives the best result as compared to other methods for feature selection. Using the combination of the SVM classifier with the PSO method, it was observed that the accuracy, precision, recall, and F1-score were 100%.

The result of the study indicates that with optimal features with the best choice of the classifier algorithm, the most accurate computer-aided diagnosis of CXR can be achieved. The approach presented in this study with optimal features may be utilized as a complementary tool to assist the radiologist in the early diagnosis of disease and making a more accurate decision.

The liver is a key organ involved in a wide range of functions, whose damage can lead to chronic liver disease (CLD). CLD accounts for more than two million deaths worldwide, becoming a social and economic burden for most countries. Among the different factors that can cause CLD, alcohol abuse, viruses, drug treatments, and unhealthy dietary patterns top the list. These conditions prompt and perpetuate an inflammatory environment and oxidative stress imbalance that favor the development of hepatic fibrogenesis. High stages of fibrosis can eventually lead to cirrhosis or hepatocellular carcinoma (HCC). Despite the advances achieved in this field, new approaches are needed for the prevention, diagnosis, treatment, and prognosis of CLD. In this context, the scientific com-munity is using machine learning (ML) algorithms to integrate and process vast amounts of data with unprecedented performance. ML techniques allow the integration of anthropometric, genetic, clinical, biochemical, dietary, lifestyle and omics data, giving new insights to tackle CLD and bringing personalized medicine a step closer. This review summarizes the investigations where ML techniques have been applied to study new approaches that could be used in inflammatory-related, hepatitis viruses-induced, and coronavirus disease 2019-induced liver damage and enlighten the factors involved in CLD development.

The use of routine laboratory biomarkers plays a key role in decision making in the clinical practice of COVID-19, allowing the development of clinical screening tools for personalized treatments. This study performed a short-term longitudinal cluster from patients with COVID-19 based on biochemical measurements for the first 72 h after hospitalization. Clinical and biochemical variables from 1039 confirmed COVID-19 patients framed on the “COVID Data Save Lives” were grouped in 24-h blocks to perform a longitudinal k-means clustering algorithm to the trajectories. The final solution of the three clusters showed a strong association with different clinical severity outcomes (OR for death: Cluster A reference, Cluster B 12.83 CI: 6.11−30.54, and Cluster C 14.29 CI: 6.66−34.43; OR for ventilation: Cluster-B 2.22 CI: 1.64−3.01, and Cluster-C 1.71 CI: 1.08−2.76), improving the AUC of the models in terms of age, sex, oxygen concentration, and the Charlson Comorbidities Index (0.810 vs. 0.871 with p < 0.001 and 0.749 vs. 0.807 with p < 0.001, respectively). Patient diagnoses and prognoses remarkably diverged between the three clusters obtained, evidencing that data-driven technologies devised for the screening, analysis, prediction, and tracking of patients play a key role in the application of individualized management of the COVID-19 pandemics.